A detailed history of Profund Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 48,669 shares of MRK stock, worth $4.86 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
48,669
Previous 47,104 3.32%
Holding current value
$4.86 Million
Previous $5.83 Million 5.23%
% of portfolio
0.21%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $173,949 - $201,838
1,565 Added 3.32%
48,669 $5.53 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $230,020 - $247,039
-1,858 Reduced 3.79%
47,104 $5.83 Million
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $254,676 - $296,755
-2,249 Reduced 4.39%
48,962 $6.46 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $212,982 - $231,776
2,126 Added 4.33%
51,211 $5.58 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $103,670 - $115,130
-1,007 Reduced 2.01%
49,085 $5.05 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $107,198 - $116,841
987 Added 2.01%
50,092 $5.78 Million
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $216,997 - $242,124
-2,108 Reduced 4.12%
49,105 $5.22 Million
Q4 2022

Feb 02, 2023

SELL
$87.44 - $112.11 $36,637 - $46,974
-419 Reduced 0.81%
51,213 $5.68 Million
Q3 2022

Nov 04, 2022

SELL
$84.53 - $94.96 $334,992 - $376,326
-3,963 Reduced 7.13%
51,632 $4.45 Million
Q2 2022

Aug 01, 2022

SELL
$83.49 - $94.64 $506,450 - $574,086
-6,066 Reduced 9.84%
55,595 $5.07 Million
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $483,622 - $542,109
-6,579 Reduced 9.64%
61,661 $5.06 Million
Q4 2021

Feb 08, 2022

BUY
$72.28 - $90.54 $51,969 - $65,098
719 Added 1.06%
68,240 $5.23 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $30,248 - $33,266
422 Added 0.63%
67,521 $5.07 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $7,734 - $8,554
110 Added 0.16%
67,099 $5.22 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $161,476 - $190,202
-2,345 Reduced 3.38%
66,989 $5.16 Million
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $2.16 Million - $2.39 Million
-30,051 Reduced 30.24%
69,334 $5.67 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $1.07 Million - $1.21 Million
-14,596 Reduced 12.81%
99,385 $8.24 Million
Q2 2020

Aug 03, 2020

BUY
$70.42 - $80.13 $1.78 Million - $2.03 Million
25,286 Added 28.51%
113,981 $8.81 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $1.63 Million - $2.26 Million
-25,736 Reduced 22.49%
88,695 $6.82 Million
Q4 2019

Feb 18, 2020

BUY
$77.58 - $87.54 $514,510 - $580,565
6,632 Added 6.15%
114,431 $10.4 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $1.28 Million - $1.39 Million
16,759 Added 18.41%
107,799 $9.08 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $1.48 Million - $1.73 Million
-21,191 Reduced 18.88%
91,040 $7.63 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $400,224 - $456,478
-5,752 Reduced 4.88%
112,231 $9.33 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $1.82 Million - $2.12 Million
-27,969 Reduced 19.16%
117,983 $9.02 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $1.18 Million - $1.39 Million
20,460 Added 16.3%
145,952 $10.4 Million
Q2 2018

Aug 13, 2018

SELL
$50.83 - $59.72 $706,282 - $829,809
-13,895 Reduced 9.97%
125,492 $7.62 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $335,418 - $389,851
-6,582 Reduced 4.51%
139,387 $7.59 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $1.88 Million - $2.25 Million
-36,456 Reduced 19.98%
145,969 $8.21 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $326,967 - $351,823
5,573 Added 3.15%
182,425 $11.7 Million
Q2 2017

Aug 11, 2017

BUY
N/A
176,852
176,852 $11.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.